AbbVie Inc. (ABBV) revenue & profit

AbbVie Inc. (ABBV): revenue $61.2B, net income $4.2B in 2025; latest quarter +10.2% year over year. From SEC filings.

$61.2BRevenue 2025

TickerABBV (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$61.2B

Net income 2025$4.2B

Net margin6.9%

Annual revenue growth+8.6%

Latest quarter (2026 Q2) · Revenue$17B

vs. same quarter last year+10.2%

Latest quarter · Net income$3.6B

Annual revenue & net income

Year	Revenue	Net income
2022	$58.1B	$11.8B
2023	$54.3B	$4.9B
2024	$56.3B	$4.3B
2025	$61.2B	$4.2B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · AbbVie Inc. · Public domain · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.